ATP13A3 and pulmonary arterial hypertension: Additionally, specific PAH‐associated ATP13A3 variants demonstrate loss‐of‐function effects, and mice with an ATP13A3 variant developed a PAH phenotype, highlighting its role in disease pathogenesis [61].